Загрузка...
PDGF-BB and IL-4 co-overexpression is a potential strategy to enhance mesenchymal stem cell-based bone regeneration
BACKGROUND: Mesenchymal stem cell (MSC)-based therapy has the potential for immunomodulation and enhancement of tissue regeneration. Genetically modified MSCs that over-express specific cytokines, growth factors, or chemokines have shown great promise in pre-clinical studies. In this regard, the ant...
Сохранить в:
| Опубликовано в: : | Stem Cell Res Ther |
|---|---|
| Главные авторы: | , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7792350/ https://ncbi.nlm.nih.gov/pubmed/33413614 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13287-020-02086-8 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|